<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0375-0760</journal-id>
<journal-title><![CDATA[Revista Cubana de Medicina Tropical]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cubana Med Trop]]></abbrev-journal-title>
<issn>0375-0760</issn>
<publisher>
<publisher-name><![CDATA[Centro Nacional de Información de Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0375-07601996000100007</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Nuevo medio sólido para el crecimiento de Borrelia persica y Borrelia microti]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[BAHRMAND]]></surname>
<given-names><![CDATA[A.R]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[NEKOUI]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[ARDEKANI]]></surname>
<given-names><![CDATA[A.M]]></given-names>
</name>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Instituto de Medicina Tropical Pedro Kourí  ]]></institution>
<addr-line><![CDATA[Ciudad de La Habana ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>1996</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>1996</year>
</pub-date>
<volume>48</volume>
<numero>1</numero>
<fpage>40</fpage>
<lpage>44</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0375-07601996000100007&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0375-07601996000100007&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S0375-07601996000100007&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Se describe un nuevo medio sólido para la rápida detección de Borrelia persica y Borrelia microti. Corrientemente el cultivo y aislamiento de Borrelia demora alrededor de 21 días. El examen serológico más frecuentemente realizado demora menos tiempo pero está asociado con resultados falsos positivos relativamente altos. Sin embargo, nuestro nuevo medio sólido reduce el tiempo de cultivo a 72 horas, lo que permite un rápido diagnóstico de la enfermedad causada por Borrelia persica y Borrelia microti y el inicio temprano del tratamiento en estos pacientes.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[BORRELIA]]></kwd>
<kwd lng="es"><![CDATA[INFECCIONES POR BORRELIA]]></kwd>
<kwd lng="es"><![CDATA[INFECCIONES POR BORRELIA]]></kwd>
<kwd lng="es"><![CDATA[REACCIONES FALSO POSITIVAS]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <HTML>  <HEAD>     <META HTTP-EQUIV="Content-Type" CONTENT="text/html; charset=iso-8859-1">     <META NAME="Generator" CONTENT="Microsoft Word 97">     <META NAME="Template" CONTENT="D:\MICROSOFT OFFICE\OFFICE\html.dot">     <META NAME="GENERATOR" CONTENT="Mozilla/4.04 [en] (Win95; I) [Netscape]">     <TITLE>Nuevo medio s&oacute;lido para el crecimiento de Borrelia persica y Borrelia micro</TITLE>  <LINK REL=STYLESHEET HREF=../mtrstyle.css TYPE="text/css">  </HEAD> <H5> Rev Cubana Med Trop 1996;48(1)</H5> Departament of Microbiology, Pasteur Institute, Tehran-Iran  <H2> <FONT COLOR="#006600"><B><font color="#000000">Nuevo medio s&oacute;lido    para el crecimiento de</font></B> <font color="#000000"><I>Borrelia persica</I><B>    y </B><I>Borrelia microti</I></font></FONT></H2>  A.R. BAHRMAND, H. NEKOUI y A.M. ARDEKANI  <H3>    <HR ALIGN=LEFT WIDTH="100%"></H3>    <h4> <B>RESUMEN</B></h4>     <p>Se describe un nuevo medio s&oacute;lido para la r&aacute;pida detecci&oacute;n    de <I>Borrelia persica</I> y <I>Borrelia microti.</I> Corrientemente el cultivo    y aislamiento de <I>Borrelia </I>demora alrededor de 21 d&iacute;as. El examen    serol&oacute;gico m&aacute;s frecuentemente realizado demora menos tiempo pero    est&aacute; asociado con resultados falsos positivos relativamente altos. Sin    embargo, nuestro nuevo medio s&oacute;lido reduce el tiempo de cultivo a 72    horas, lo que permite un r&aacute;pido diagn&oacute;stico de la enfermedad causada    por <I>Borrelia persica</I> y <I>Borrelia microti</I> y el inicio temprano del    tratamiento en estos pacientes.     <BR>   <B>Palabras clave:</B> <I>BORRELIA</I>/aislamiento &amp; purificaci&oacute;n;    INFECCIONES POR <I>BORRELIA</I>/diagn&oacute;stico; INFECCIONES POR<I> BORRELIA</I>/terapia,    REACCIONES FALSO POSITIVAS.</p> <h4> INTRODUCTION</h4>  The genus <I>Borrelia</I> contains the spirochetes which cause relapsing  fever and lyme disease in man1 and diseases in domestic animals and rodents.2,3  <I>Borrelia </I>are generally transmitted from its usual wildlife reservoirs  to humans and domestic animals via ticks belonging to the class ornithodorous  or class Ixodes which cause the lyme disease.4,5 The studies of these bacteria  are very important due to their presence and rapid spread throughout the  world including Iran.        <P>Four species of <I>Borrelia </I>which have been isolated from man and  animals in Iran are: <I>B. persica, B. microti, B. baltazardi, B. latichewi.  </I>Two species, <I>B. microti </I>and <I>B. persica </I>have been identified  to be the causing agents of relapsing fever in Iran6,7,8 rather than <I>B.  hermsii </I>which is well known to be the cause of relapsing fever in the  west. These bacterial species have been shown to vary in kind and have  great antigenic variability.9-12 In order to study the antigenic variability  of <I>Borrelia </I>species which are known to be caused by DNA rearrangements  on their linear plasmids,13,14 isolation of single colonies is of special  importance in molecular studies of the disease. For the first time after  great efforts,15,16 kelly could prepare liquid medium for culturing<I>  B. hermsii. </I>Then, <I>Babour </I>and his colleagues by changing the  contents of Kelly's medium were able to culture <I>B. burgdorferi.</I>17  This method however, is not suitable for isolation of single<I> Borrelia  </I>colonies for molecular studies. The growth of these bacteria on solid  media has been very difficult when observed by inverted microscope after  three weeks of growth.1,18 In this study we report a new solid medium for  growing <I>B. microti </I>and <I>B. persica </I>known to cause relapsing  fever17 in Iran. This medium allows a very rapid growth of the bacteria  in 72 hours in comparison with the currently used media (solid or liquid)  which takes about 10-21 days.  <H3>  MATERIALS AND METHODS</H3>  The two species of <I>Borrelia persica </I>and<I> Borrelia microti </I>in  our hands at Pasteur Institute were isolated from the ticks collected from  the north western and north eastern regions of Iran. A stock of these bacteria  are usually kept in the laboratory by culturing them in animal laboratories  such as mice and guinea pigs.  <H3>  SOLID CULTURE MEDIUM (SCM)</H3>  This medium is made up of 2 major components.        <P>FRACTION I:        <P>A) 50 gram of bovine serum albumin dissolved in 600 mL of ddH2O.        <P>B) The following compounds were dissolved in 200 mL of ddH2O and its  pH was adjusted to 7,6:  <OL>      <LI>  Neopeptone 5 g</LI>        <LI>  HEPES 6 g</LI>        <LI>  Sodium Citrate 0,7 g</LI>        ]]></body>
<body><![CDATA[<LI>  Glucose 5 g</LI>        <LI>  Sodium Pyruvate 0,8 g</LI>        <LI>  N. acetylglucosamine0,4 g</LI>        <LI>  Sodium bicarbonate 2,2 g</LI>        <LI>  Yeast Extract 2,53 g</LI>        <LI>  TC Medium 199 (10X) 100 mg</LI>      </OL>  Items number 2,3,4,5,6,7 were all purchased from Sigma and Items 1,8,9,  were purchased from Difco.        <P>C) 28 grams of gelatin were dissolved in 100 mL of ddH2O then autoclaved  at 121 oC for 15 min.        <P>The solutions made in steps A,B,C were heated to 40 oC, mixed and filtered  (0,22 m). Then the following antibiotic solutions were added to the solution:  Kanamycin 8 mg/mL (Bristol laboratories, N.Y.), and 5-Fluorouracil 230  mg/mL (Roche laboratories, N.J.).        <P>FRACTION II:        ]]></body>
<body><![CDATA[<P>A) 1,7 g agarose with low electroendosmosis was dissolved in 20 mL of  ddH2O and autoclaved at 121 oC for 15 min.        <P>B) 4,6 mL inactive fresh and sterile rabbit serum (Sigma).        <P>C) 5,3 mL of sterile 5 % sodium bicarbonate.        <P>The solutions in steps A,B,C were mixed and kept at 4 oC.  <H3>  FINAL CULTURE AND MEDIUM PREPARATION</H3>  Heat the 100 mL bottles containing fractions I &amp; II to 40 oC, mix and  then distribute to petri dishes under laminar hood.        <P>BORRELIA PERSICA <B>CULTURE</B>        <P>Four guinea pigs (300g each) were injected peritoneally with 0,5 mL  spirochetemia blood collected in sterile test tube containing 0,1 mL of  4 % sodium citrate. After 5 days post injection time, 2 mL of septicimic  spirochetemia guinea pig blood were drawn and 0,1 mL were put on slide  (1 cm2 marked area) and viable cells were counted in triplicate experiments  30 times. The result indicated average of 10 bacteria under 40X magnification.  From 2 mL of spirochetemia guinea pig blood containing 10 bacteria under  40X magnification, 0,2 mL of blood was spread on each petri-dish containing  the SCM. Then they were put in a Jar along with a tube containing 20 mL  of sterile distilled H2O for humidity purpose. In order to create an anaerobic  or microaerophilic condition, the eandle method or a special gas pack was  used.18 After the candle was out, they were put in a 34 oC incubator.        <P>BORRELIA MICROTI <B>CULTURE</B>        <P>0,5 mL of spirochetemia blood was taken from white mouse which contained  20 bacteria under 40X magnification. 0,1 mL of blood was spread on each  petri-dish containing the SCM. The rest of the procedure used was the same  as<I> B. persica.</I>18        <P>COLONY COUNT AND GROWTH MEASUREMENT        <P>BORRELLA <B>GROWTH CURVE</B>        ]]></body>
<body><![CDATA[<P>For obtaining the growth curve of <I>B. persica</I> and <I>B. microti</I>  the procedure used was as follows: 1 mL suspension of liquid culture containing  of <I>B. persica</I> and <I>B. microti</I> containing 100 organisms were  kept separately in two test tubes at 4 oC. To analyse their growth 30 agar  plates containing SCM were used and 3 drops (0,1 mL each) of suspension  were placed in 3 selected areas (approx 1 cm2 circle marked) on each plate  for each <I>Borrelia</I> species. Then, the plates were put in an anaerobic  Jar and incubated at 3-4 oC. Every 12 hours one plate was taken out from  the Jar and the bacterial growth was determined. Every selected areas where  the bacteria were grown, was isolated and completely suspended in sterile  physiological serum. From this suspension serial dilutions of 1/10, 1/100,  1/1 000 were prepared and 0,1 mL from each dilution was taken to be put  on the surface of slide (marked 1 cm2). After fixing with methanol, the  slide was stained in 10 % Giemsa for 20 minutes. Finally the bacteria were  counted under 100X objective lens. During the early hours when the number  of bacteria were low the 1/10 dilution and with the increased in growth,  1/100 and 1/1 000 dilutions were used. As figures 1, and 2 show growth  of the bacteria started from the 36th hour (lag phase), and maximized at  120th (log phase) hour. Then, the number of bacteria remained constant  until 216th hour (stationary phase). Then, the number of bacteria started  to decrease (decline phase). The viable cell counts of <I>B. persica</I>  in this medium reached 1 x 106 and<I> B. microti</I> reached 1 x 107 and  the generation time for <I>B. persica</I> was measured to be 9:55 hours  and for <I>B. microti</I> 6:25 hours.  <H3>  RESULTS</H3>  Tables 1 and 2 summarize the growth of <I>B. persica</I> and <I>B. microti  </I>respectively. Subculturing both <I>B. persica</I> and <I>B. microti</I>  after passages in guinea pigs, liquid culture, and white laboratory mice  show a more than 2X viable cell increase if the rabbit serum was added  in the SCM. Similar results were not obtained when guinea pig serum were  used. Figures 1 and 2 indicate reduced microscopic detection time to observe<I>  B. persica</I> and <I>B. microti</I> colonies to 72 hours.  <H3>  DISCUSSION</H3>  We have shown in this study that <I>B. microti</I> and <I>B. persica</I>  can be grown in a newly developed SCM enabling the investigators to have  single isolated colonies in 72 h. This medium can be easily obtained and  prepared in a microbiology laboratory. As tables 1 and 2 show both species  of <I>Borrielia </I>have grown well in SCM when rabbit serum was used.  However, guinea pig serum used in SCM did not support the growth of <I>B.  persica</I>. This finding was in support ofearlier studies which showed  that guinea pigs and white laboratory mice are naturally sensitive to <I>B.  persica</I> and <I>B. microti </I>respectively.8 In this study we have  used TC medium 199 used in tissue culture. This medium contains not only  amino acids of type D but also of type I, which are important in the synthesis  of glucopeptides necessary for the formation of bacterial cell wall and  rapid growth of the bacteria19 (Razavi M. Antigenic cross reactivation  in <I>Borrelia spp.</I> in Iran [MS. Thesis]. 1988:88). The colonies formed  on the SCM are detectable in 72 hours and characteristically are dome shape  with the smooth periphery, colorless and 0,2-0,8 mm in diameter.        <P>The pathogenic species of the genus <I>Borrelia</I> are antigenetically  heterogeneous between strains and are variable in the expression of certain  outer surface proteins within a strain.<I> B. hermsii</I>, is the most  studied type of <I>Borrelia</I> species causing relapsing fever in the  west. However, the species causing this disease in Iran are <I>B. microti</I>  and <I>B. persica.</I>8 In order to study the plasmids of individual strains  one has to be able to isolate the strain and the unique plasmids belonging  to that strain. Therefore preparation of a solid medium for helping us  to achieve this goal was an essential first step. In this study we have  shown that our SCM has reduced the time required to grow and to observe  <I>B. persica</I> and <I>B. microti</I> colonies on the surface of SCM  to 72 hours rather than 3 weeks which is requiered for growth when other  media are used.16 Our results as shown in figures 1 and 2 indicate that  growth of the two <I>Borrella</I> species started from the 36th hour and  maximized at 120th hour. Then, the number of bacteria remained constant  until 216th hour and gradually decreased thereafter. The generation time  for <I>B. microti</I> and <I>B. persica</I> was found to be 6:25 hours  and 9:55 hours respectively. The generation time calculated when these  two species are grown in liquid culture in our laboratory have shown to  be 8:40 hours and 15:40 hours respectively. The shorter generation time  observed between the two types of culture regarding each species is probably  due to the richness of the SCM. The growth of these two species in SCM  do not seem to cause any differences in virulency since injection of them  into swiss white mouse and guinea pig cause spirochetemia in less than  3 days (unpublished data). Our laboratory does not grow <I>Borrelia</I>  species other than <I>B. microti</I> and <I>B. persica</I>. However, we  expect SCM to be used for the growth of other <I>Borrelia</I> species as  well.  <H3>  ACKNOWLEDGEMENT</H3>  We would to thang our colleagues <I>M.R. Razavi</I>, <I>A. Amirkhani</I>,<I>  M. Amiri</I> and <I>H. Norouzi</I> for their assitance.  <H3>  REFERENCIAS BIBLIOGRAFICAS</H3>    <OL>      <LI>  Valc&aacute;rcel Novo M, Rodr&iacute;guez Cruz R, Terry Molinert H. La  enfermedad meningoc&oacute;cica en Cuba: cronolog&iacute;a de una epidemia.  La Habana: Editorial Ciencias M&eacute;dicas, 1990:81-7.</LI>        <LI>  Cuba. Ministerio de Salud P&uacute;blica. Cuadro epidemiol&oacute;gico.  La Habana; 1992:5-16.</LI>        <LI>  Sierra VG, Campa C, Valc&aacute;rcel M, Sotolongo F, Figueredo L, Izquierdo  L. Efficacy evaluation of the Cuban vaccine VA- MENGOC BC against disease  caused by serogroup B Nisseria meningitidis. En: Markachtman C, et al,  eds. Neisseria 1990. Proceedings of the Seventh International Conference  on Pathogen Neisserias; 1990 Sept 9-14; Berlin, Federal Republic of Germany.  Berlin: Walter Dgruyter, 1992:129.</LI>        <LI>  Halloran ME, Haber M, Longini I, Struchiner C. Direct and indirect effects  in vaccine efficacy and effectiveness. Am J Epidemiol 1991;133(4):323-31.</LI>        <LI>  S&aacute;ez-Nieto JA. Campos J, Latorre C, Juncosa T, Sierra M, Garc&iacute;a-Barrero  B. Prevalence of <I>Nisseria meningitidis</I> in Family members of patients  with meningococal infection. J Hyg Camb 1982;89:139-47.</LI>      </OL>  Recibido: 18 de febrero de 1993. Aprobado: 6 de junio de 1993.        <P>Dr. <I>Osvaldo Rico Cordeiro.</I> Instituto de Medicina Tropical "Pedro Kour&iacute;".    Apartado 601, Marianao 13, Ciudad de La Habana, Cuba.     <DIV ALIGN=right></DIV>        ]]></body>
<body><![CDATA[</body>  </HTML>       ]]></body><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valcárcel Novo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez Cruz]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Terry Molinert]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[La enfermedad meningocócica en Cuba: cronología de una epidemia]]></source>
<year>1990</year>
<page-range>81-7</page-range><publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Editorial Ciencias Médicas]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="">
<collab>Ministerio de Salud Pública</collab>
<source><![CDATA[Cuadro epidemiológico]]></source>
<year>1992</year>
<page-range>5-16</page-range><publisher-loc><![CDATA[La Habana ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sierra]]></surname>
<given-names><![CDATA[VG]]></given-names>
</name>
<name>
<surname><![CDATA[Campa]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Valcárcel]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sotolongo]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Figueredo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Izquierdo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Efficacy evaluation of the Cuban vaccine VA- MENGOC BC against disease caused by serogroup B Nisseria meningitidis]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Markachtman]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Neisseria 1990: Proceedings of the Seventh International Conference on Pathogen Neisserias; 1990 Sept 9-14; Berlin, Federal Republic of Germany]]></source>
<year>1992</year>
<page-range>129</page-range><publisher-loc><![CDATA[Berlin ]]></publisher-loc>
<publisher-name><![CDATA[Walter Dgruyter]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Halloran]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Haber]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Longini]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Struchiner]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Direct and indirect effects in vaccine efficacy and effectiveness]]></article-title>
<source><![CDATA[Am J Epidemiol]]></source>
<year>1991</year>
<volume>133</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>323-31</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sáez-Nieto]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Campos]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Latorre]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Juncosa]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Sierra]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[García-Barrero]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Prevalence of Nisseria meningitidis in Family members of patients with meningococal infection]]></article-title>
<source><![CDATA[J Hyg Camb]]></source>
<year>1982</year>
<volume>89</volume>
<page-range>139-47</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
